A Study of the Safety and Effectiveness of the Mentor Smooth and Textured Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction

Status: Active_not_recruiting
Location: See all (30) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study will evaluate the safety and effectiveness with the Mentor MemoryGel® Larger Size Ultra High Profile (UHP-L) Breast Implants.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Subject is female and is at least 18 years old

• A candidate for:

• Primary breast reconstruction in women at least 18 years old with surgically absent breast tissue (two-stage reconstruction \[tissue expanders utilized with or without the use of human acellular dermal matrices (ADM), limited to AlloDerm® and FlexHD® PLIABLE, utilized in a prior surgery to expand tissue for study device placement\] to replace breast tissue post-mastectomy)

• Revision surgery in women at least 18 years old with surgically absent breast tissue (previous reconstruction with silicone-filled or saline-filled implants or revision reconstruction requiring expansion surgery prior to surgery for study device implantation, with or without the use of human acellular dermal matrices (ADM), limited to AlloDerm® and FlexHD® PLIABLE, utilized in a prior surgery to expand tissue for study device placement)

• Subject understands and signs the Informed Consent

• Subject agrees to return device to Mentor if device is explanted

• Subject agrees to comply with follow-up procedures, including returning for all follow-up visits

• Physician determines implant volume appropriate for the patient taking into account the subject's BMI and chest width

Locations
United States
Alabama
Plastic Surgery Associates of Montgomery
Montgomery
Arizona
Mayo Clinic Arizona - Scottsdale/Phoenix (MCSB)
Phoenix
Mosharrafa Plastic Surgery
Phoenix
Andres Plastic Surgery
Scottsdale
California
Adventist Health Bakersfield
Bakersfield
Susan E Downey MD, Inc
Burbank
Liu Plastic Surgery
Los Gatos
Stanford University School of Medicine
Stanford
Georgia
Buckhead Plastic Surgery, P.C
Atlanta
Georgia Institute of Plastic Surgery
Savannah
Iowa
University of Iowa Hospitals & Clinics
Iowa City
Indiana
The Centre, PC
Mishawaka
Kansas
The University of Kansas
Kansas City
Minnesota
Abbott Northwestern Hospital
Minneapolis
Missouri
Washington University School of Medicine
Saint Louis
New York
The Mount Sinai Medical Center
New York
Ohio
Plastic Surgery Institute of Dayton
Centerville
The Plastic Surgery Group
Cincinnati
The Cleveland Clinic
Cleveland
The Ohio State University Plastic Surgery
Columbus
Oregon
Legacy Good Samaritan Medical Center
Portland
Pennsylvania
Paul Glat, MD, PC
Bala-cynwyd
Hospital of the University of Pennsylvania
Philadelphia
Tennessee
The Center for Dermatology and Plastic Surgery at Springbrook
Alcoa
The Plastic Surgery Group PC
Chattanooga
Vanderbilt University Medical Center
Nashville
Texas
Houston Methodist Hospital
Houston
The University of Texas MD Anderson Cancer Center
Houston
Baylor Scott & White Health
Temple
Virginia
UVA Health System
Charlottesville
Time Frame
Start Date: 2016-04-01
Completion Date: 2029-01-31
Participants
Target number of participants: 400
Treatments
Experimental: Primary Breast Reconstruction
Participants who meet the requirements for primary breast reconstruction (have not had previous silicone or saline breast implants, not including tissue expanders) and have been implanted with Mentor Larger Size MemoryGel Ultra High Profile Breast implants
Experimental: Revision Breast Reconstruction
participants who meet the requirements for revision breast reconstruction (have had previous silicone or saline breast implants) and have been implanted with Mentor Larger Size MemoryGel Ultra High Profile Breast implants
Sponsors
Leads: Mentor Worldwide, LLC

This content was sourced from clinicaltrials.gov